ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -28 مورد

Acute mountain sickness risk

Acute mountain sickness risk
Variable Risk category
Low Moderate High
History of acute altitude illness  None or mild AMS  Moderate-severe AMS  HAPE or HACE
Sleeping elevation on Day 1 (meters)  <2800  2800 to 3500  >3500
Ascent rate (meters/day)  ≤500 m/d above 3000 m with extra days for acclimatization every 1000 m  ≥500 m/d above 3000 m with extra days for acclimatization every 1000 m  ≥500 m/d above 3000 m without extra days for acclimatization every 1000 m
Assessing the risk of acute altitude illness. Medical history and features of the planned ascent can be used to assess the risk of acute altitude illness after ascent. Check marks should be placed in the boxes that best describe the variables in the left-hand column. The risk of a planned ascent is determined by the farthest column to the right in which a check mark is placed. This assessment applies to unacclimatized individuals. Ascent is assumed to start from elevations <1200 m. A history of acute altitude illness does not necessarily reflect high risk with all future ascents, as a slower ascent rate or lower target elevation on subsequent trips may help avoid problems. The risk of travel above any given elevation can be mitigated by ensuring an appropriately slow rate of ascent.
AMS: acute mountain sickness; HACE: high altitude cerebral edema; HAPE: high altitude pulmonary edema.
From: Luks AM, Beidleman BA, Freer L, et al. Wilderness Medical Society Clinical Practice Guidelines for the Prevention, Diagnosis, and Treatment of Acute Altitude Illness: 2024 Update. Wilderness & Environmental Medicine 35(1_suppl), pp. 2S-19S. Copyright © 2023 by the Wilderness Medical Society. Reprinted by permission of Sage Publications, Inc.
Graphic 145969 Version 1.0